Results from COG0201: a Randomized, Placebo-controlled, Double-blind, International, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Adults with Mild-to-Moderate Alzheimer&#39;s Disease

Elayta (CT1812) - Cognition Therap

https://www.ctad-alzheimer.com/files/files/PROGRAM_CTAD2024_WEB%20October%2018.pdf

Michael Woodward 1; Everard Vijverberg 2, 3; Susan Catalano 4; Theresa Devins 5; Valentina Di Caro 5; Michael Grundman 6; Mary Hamby 5; Jennifer Iaci 5; Anthony Caggiano 5

Aug 31, 2024